Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
Host institution: NIMH Unit, Inserm-EPHE-Université de Caen Normandie U1077 (https://nimh.unicaen.fr/fr/accueil/ ) Supervision: Dr Peggy Quinette, Associate Professor in Psychology, Université de Caen
-
application, to ultimately benefit patients. The PhD candidate will be co-supervised by Dr. Olivier Ayrault (Children's Oncology Research Unit, Inserm U1330 / CNRS EMR 8001) and Dr. Alexandre Baffet (Cell
-
preparation of scientific publications related to the project. The postdoc will work in close collaboration with a network of bioinformaticians specializing in the design and development of data analysis
-
Cardioembolic Stroke Risk Stratification using AI Accelerated Patient-Specific Blood Flow Simulation
thrombogenesis. In this PhD project at Inria, in collaboration with the iCV team from Laboratoire d'Imagerie Biomédicale-LIB (Sorbonne University, Inserm), and the M2P2 team (Aix-Marseille University), we will
-
Location: ARNA and CBMN Laboratories, Campus Carreire, University of Bordeaux / Inserm / CNRS Supervision: Thibaud Renault (CNRS Research Scientist, ARNA) and Gilles Joucla (Associate Professor, CBMN
-
. At Inserm U1105, we have shown that the brain of premature newborns encodes auditory rhythms and synchronizes with them in a predictive manner. These abilities develop progressively during the third trimester
-
CNRS and INSERM. It is part of an internationally recognized institution focused on cutting-edge research in computational biology, cancer, and infectious diseases. The team combines expertise from
-
follow the official INSERM scales. The position provides opportunities for independence, international networking, and leadership development in preparation for future fellowships. Eligibility criteria
-
12 Feb 2026 Job Information Organisation/Company Inserm PACA Corsica Department iBV - U1091 Research Field Biological sciences » Biology Researcher Profile First Stage Researcher (R1) Positions
-
Unit, UMR 8199/ U1283 CNRS, INSERM, Institut Pasteur de Lille, CHU Lille, Université Lille) in the “Metabolome, Microbiome and Metabolic Diseases” team and the metabolomic platform IMPACT-PM, directed by